Indrayani Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indrayani Biotech Ltd. on BSE

Load latest

Indrayani Biotech Ltd.

10 Jan 2024

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of …

BSE India

Pursuant to Regulation 30 of SEBI LODR, the Board of Directors of the Company, at their meeting held today, January 10, 2024, have inter-alia considered the following: Recommendations to get the approval from the shareholders of the Company through postal ballot for the following Increase of authorised share capital from Rs.46 crores to Rs.65 crores and consequential amendment to the capital clause of the memorandum of association of the Company Amendment in the Articles of association of the Company Summary of the proposed amendments in Memorandum and Articles of association of the Company are provided in the annexure.

pdf

Indrayani Biotech Ltd.

10 Jan 2024

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

The Board of Directors of the Company, at their meeting held on today, January 10, 2024, have inter-alia considered and approved the following matters: Recommendations to get approval from shareholders of the Company through postal ballot for the below mentioned items: To consider and to grant approval to increase authorised share capital To consider and to grant approval to amend the Articles of Association of the Company To consider and approve an amendment in the terms and conditions of existing unsecured loan arrangements availed from Mr. Kasiraman Sayee Sundar, Managing Director & M/s. Bougainvillea Investments Private Limited Took note of the resignation of Mr. Rajesh Kumar Sundarray (ACS membership number: A66744) as Company Secretary & Compliance Officer with effect from closing hours on January 10, 2024 and has appointed Mr. V Santhanakrishnan (ACS membership number: A54146) for the position of Company Secretary & Compliance Officer with effect from January 11, 2024.

pdf

Indrayani Biotech Ltd.

06 Jan 2024

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Intimation for Proposal For Increasing The Authorised Share …

BSE India

INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/01/2024 ,inter alia, to consider and approve To consider the proposal for increasing the authorized share capital subject to the shareholders' approval. To consider and approve the conversion of unsecured loans into equity under Section 62(3) of the Companies Act, 2013 subject to the shareholders' approval. Any other business with the permission of the Chair.

pdf

Indrayani Biotech Ltd.

01 Jan 2024

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Updates At Dindigul Farm Product Limited, A Material Subsidiary Of …

BSE India

Pursuant to Regulation 30 of SEBI LODR, Indrayani Biotech Limited inform the following updates from Dindigul Farm Product Limited, a material subsidiary of the Company: 1. Dindigul Farm Product Limited, has filed draft red herring prospectus dated December 31, 2023 in BSE for SME-IPO (Small and Medium Enterprises Initial Public Offer), subject to market conditions, receipt of applicable approvals and other considerations. 2. Dindigul Farm Product Private Limited was converted as a Public Company with name of Dindigul Farm Product Limited. The Company will make further announcements of all material developments relating to IPO, as and when required, as per SEBI LODR and other applicable laws.

pdf

Indrayani Biotech Ltd.

29 Dec 2023

SAST

INDRAYANI BIOTECH LTD. - 526445 - Closure of Trading Window

BSE India

Indrayani Biotech Limited has informed the exchange about closure of Trading window from January 1, 2024 till 48 hours after the declaration of unaudited financial results for the quarter and nine months ended December 31, 2023.

pdf

Indrayani Biotech Ltd.

06 Dec 2023

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015 is enclosed.

pdf

Indrayani Biotech Ltd.

02 Dec 2023

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015 is enclosed.

pdf

Indrayani Biotech Ltd.

25 Nov 2023

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015 is enclosed

pdf

Indrayani Biotech Ltd.

15 Nov 2023

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Enclosed herewith the copy of news paper publications pertaining to unaudited financial results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2023.

pdf

Indrayani Biotech Ltd.

14 Nov 2023

Result

INDRAYANI BIOTECH LTD. - 526445 - Unaudited Financial Results For The Quarter And Half Year Ended …

BSE India

Pursuant to Regulation 33 of SEBI (LODR) Regulations 2015, the Board of directors in its Meeting held on today i.e. 14/11/2023 has approve the unaudited financial results for the quarter and half year ended on September 30, 2023.

pdf

Is Indrayani Biotech Ltd. worth buying?

25 Votes:

Buy 72.0%

Sell 12.0%

Hold 16.0%